Session was held on April 29, 2024
Join us for a discussion on the current legal, regulatory and policy landscape as it pertains to the use of psychedelic-assisted therapies in Canada, and emerging developments that will pose challenges and opportunities for health care organizations, clinicians and patients. We will also address the challenges and opportunities for the clinical use of psychedelics – moving from underground to the mainstream. More specifically, how to manage patients’ expectations, ensure adequate set and setting for clinical use, and the foreseeable challenges around acceptability and scalability of these medicines in clinical practice.
Host
- Dr. Jose Pereira, Pallium Canada
Presenters:
- Claudio N. Soares MD, PhD, FRCPC, MBA
- David Clements, Executive Director, Queen’s University, Health Sciences
Panelists
- Dr. Kylea Potvin, MD, FRCPC
- Dr. Lyle Galloway